| Q42564268 | 18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study. |
| Q36368922 | A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates |
| Q84750734 | Abstracts of the Ninth International Symposium on Functional Neuroreceptor Mapping of the Living Brain. August 9-11, 2012 |
| Q47120434 | Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors |
| Q42741921 | Approaches to quantify radioligands that wash out slowly from target organs |
| Q48585422 | Automated one-step radiosynthesis of the CB1 receptor imaging agent [(18) F]MK-9470. |
| Q34044002 | Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomography |
| Q38132167 | Cannabis, a complex plant: different compounds and different effects on individuals |
| Q36604291 | Characterization of fast-decaying PET radiotracers solely through LC-MS/MS of constituent radioactive and carrier isotopologues |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q42156717 | Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolase |
| Q38182651 | Dyskinesias in Parkinson's disease: views from positron emission tomography studies |
| Q57166606 | Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies |
| Q30687668 | Endocannabinoid signaling in the etiology and treatment of major depressive illness |
| Q48499558 | Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach. |
| Q41288205 | Guidelines to PET measurements of the target occupancy in the brain for drug development. |
| Q33833784 | Image-derived input function for human brain using high resolution PET imaging with [C](R)-rolipram and [C]PBR28 |
| Q34382594 | Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using (18)F-labeled inverse agonist radioligands |
| Q27321190 | Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences |
| Q37621131 | Impact of cannabis use on prefrontal and parietal cortex gyrification and surface area in adolescents and emerging adults |
| Q36267474 | Improved models for plasma radiometabolite correction and their impact on kinetic quantification in PET studies |
| Q37360865 | In vitro and in vivo evaluation of (11)C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors |
| Q34278947 | In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse. |
| Q43150645 | Influence of chronic nicotine administration on cerebral type 1 cannabinoid receptor binding: an in vivo micro-PET study in the rat using [18F]MK-9470. |
| Q40670083 | Involvement of the endocannabinoid system in reward processing in the human brain |
| Q44697227 | Kinetic analysis of the cannabinoid-1 receptor PET tracer [(18)F]MK-9470 in human brain |
| Q36655387 | Mapping human brain fatty acid amide hydrolase activity with PET. |
| Q29248766 | Molecular Imaging Markers to Track Huntington’s Disease Pathology |
| Q34904406 | N-(4-cyanotetrahydro-2H-pyran-4-yl) and N-(1-cyanocyclohexyl) derivatives of 1,5-diarylpyrazole-3-carboxamides showing high affinity for 18 kDa translocator protein and/or cannabinoid receptors |
| Q30834004 | Neuroimaging in Huntington's disease |
| Q42369736 | PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease |
| Q47303206 | Pharmacokinetics of the cannabinoid receptor ligand [18 F]MK-9470 in the rat brain - Evaluation of models using microPET. |
| Q45585427 | Pharmacological characterization of the cannabinoid CB1 receptor PET ligand ortholog, [3H]MePPEP |
| Q45319384 | Platform for systems medicine research and diagnostic applications in psychotic disorders-The METSY project |
| Q35757921 | Poorer frontolimbic white matter integrity is associated with chronic cannabis use, FAAH genotype, and increased depressive and apathy symptoms in adolescents and young adults |
| Q36162168 | Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependence |
| Q48473239 | Preclinical evaluation and quantification of [¹⁸F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain |
| Q43091758 | Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR. |
| Q38028657 | Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time |
| Q37591594 | Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans |
| Q53151112 | Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model. |
| Q48502246 | Synthesis and preclinical evaluation of [¹⁸F]FCHC for neuroimaging of fatty acid amide hydrolase |
| Q38166976 | Synthetic strategies for radioligands for in vivo imaging of brain cannabinoid type-1 receptors |
| Q34812954 | Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP. |
| Q64229781 | The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder |
| Q37621168 | The impact of ADHD persistence, recent cannabis use, and age of regular cannabis use onset on subcortical volume and cortical thickness in young adults |
| Q42948746 | Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism |
| Q47566341 | Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies. |
| Q58576516 | [--C]-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1-indole-2-carboxamide ([C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D₃ Receptors in Rodents and Monkey |
| Q47565244 | [Carboxyl-11 C]Labelling of Four High-Affinity cPLA2α Inhibitors and Their Evaluation as Radioligands in Mice by Positron Emission Tomography. |
| Q34269852 | [¹²⁵I]SD-7015 reveals fine modalities of CB₁ cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's disease |